fludarabine
UkraineDrugs containing this active substance
-
The drug is intended for the treatment of B-cell chronic lymphocytic leukemia in adult patients with adequate bone marrow reserve.
Form: solution for injection, concentrate
Active substance Dosage fludarabine 25 mg/ml ATC: L01BB05
Manufacturer: Accord Healthcare Limited (additional secondary packaging)
-
The drug is intended for the treatment of B-cell chronic lymphocytic leukemia in patients with adequate bone marrow reserve.
Form: powder for solution for injection or infusion
Active substance Dosage fludarabine 50 mg ATC: L01BB05
Manufacturer: Syndan Pharma S.R.L.